Figure 3.
![Figure 3. Age and CR rate of biCEBPACCSpos, biCEBPACCSneg, and moCEBPA patients. (A) Age of biCEBPACCSneg (median = 48), biCEBPACCSpos (median = 66), and moCEBPA (median = 62) patients. Scatter dot plot, median with interquartile range. (B) The CR rate was significantly higher in biCEBPACCSneg patients (91% [20/22]) than biCEBPACCSpos (61% [14/23]; P = .035) and moCEBPA patients (P = .027).](https://ash.silverchair-cdn.com/ash/content_public/journal/bloodadvances/2/20/10.1182_bloodadvances.2018016840/4/advances016840f3.png?Expires=1736047983&Signature=DUuaPRn8EdqXlJn4RhumX8usKkxjBIdEUSxSosyjR-ZZIjXMRP3GEeEypbzgxmLQIEKGFqD6uhpqcEEtaNiZaLNLQbmZUFRHnV~GytUnmUVdKsUAWjjJLRFv34W8O2OfGRWusu2HfrJACro~sHpeh~VEIpmTzNmrQJURtLBDIuJBpLiTVOAgS92vtNV2ZAXHzBHurzk9juLgGUQEnqXBHlDSkcXi7-MkEpItv-XQmJsW26VETqCu-qROTH1SpGjktvQQnH96Avo4F03VSW4wj1g7TEh3Ts3NwVUuyp6quBzpiiCRJhtQYYEswVb3ojCqs81UgCdZgDJp6CO6uyqxjA__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)
Age and CR rate of biCEBPACCSpos, biCEBPACCSneg, and moCEBPA patients. (A) Age of biCEBPACCSneg (median = 48), biCEBPACCSpos (median = 66), and moCEBPA (median = 62) patients. Scatter dot plot, median with interquartile range. (B) The CR rate was significantly higher in biCEBPACCSneg patients (91% [20/22]) than biCEBPACCSpos (61% [14/23]; P = .035) and moCEBPA patients (P = .027).